These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35776159)

  • 1. Cancer-targeted photoimmunotherapy induces antitumor immunity and can be augmented by anti-PD-1 therapy for durable anticancer responses in an immunologically active murine tumor model.
    Hsu MA; Okamura SM; De Magalhaes Filho CD; Bergeron DM; Rodriguez A; West M; Yadav D; Heim R; Fong JJ; Garcia-Guzman M
    Cancer Immunol Immunother; 2023 Jan; 72(1):151-168. PubMed ID: 35776159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors.
    Nagaya T; Friedman J; Maruoka Y; Ogata F; Okuyama S; Clavijo PE; Choyke PL; Allen C; Kobayashi H
    Cancer Immunol Res; 2019 Mar; 7(3):401-413. PubMed ID: 30683733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near-Infrared Photoimmunotherapy of Cancer.
    Kobayashi H; Choyke PL
    Acc Chem Res; 2019 Aug; 52(8):2332-2339. PubMed ID: 31335117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity.
    Taki S; Matsuoka K; Nishinaga Y; Takahashi K; Yasui H; Koike C; Shimizu M; Sato M; Sato K
    J Immunother Cancer; 2021 Oct; 9(11):. PubMed ID: 34725216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral IL15 Improves Efficacy of Near-Infrared Photoimmunotherapy.
    Fukushima H; Furusawa A; Kato T; Wakiyama H; Takao S; Okuyama S; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2023 Oct; 22(10):1215-1227. PubMed ID: 37461129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined CD44- and CD25-Targeted Near-Infrared Photoimmunotherapy Selectively Kills Cancer and Regulatory T Cells in Syngeneic Mouse Cancer Models.
    Maruoka Y; Furusawa A; Okada R; Inagaki F; Fujimura D; Wakiyama H; Kato T; Nagaya T; Choyke PL; Kobayashi H
    Cancer Immunol Res; 2020 Mar; 8(3):345-355. PubMed ID: 31953245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Size-optimized nuclear-targeting phototherapy enhances the type I interferon response for "cold" tumor immunotherapy.
    Zhang X; Yi C; Zhang L; Zhu X; He Y; Lu H; Li Y; Tang Y; Zhao W; Chen G; Wang C; Huang S; Ouyang G; Yu D
    Acta Biomater; 2023 Mar; 159():338-352. PubMed ID: 36669551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective Photokilling of Colorectal Tumors by Near-Infrared Photoimmunotherapy with a GPA33-Targeted Single-Chain Antibody Variable Fragment Conjugate.
    Wei D; Tao Z; Shi Q; Wang L; Liu L; She T; Yi Q; Wen X; Liu L; Li S; Yang H; Jiang X
    Mol Pharm; 2020 Jul; 17(7):2508-2517. PubMed ID: 32396000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune checkpoint inhibition combined with targeted therapy using a novel virus-like drug conjugate induces complete responses in a murine model of local and distant tumors.
    Huis In 't Veld RV; Ma S; Kines RC; Savinainen A; Rich C; Ossendorp F; Jager MJ
    Cancer Immunol Immunother; 2023 Jul; 72(7):2405-2422. PubMed ID: 36997666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy.
    Mączyńska J; Raes F; Da Pieve C; Turnock S; Boult JKR; Hoebart J; Niedbala M; Robinson SP; Harrington KJ; Kaspera W; Kramer-Marek G
    BMC Med; 2022 Jan; 20(1):16. PubMed ID: 35057796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Near Infrared Photoimmunotherapy for Cancer].
    Kobayashi H
    Gan To Kagaku Ryoho; 2019 Jan; 46(1):28-33. PubMed ID: 30765637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models.
    Puigdelloses M; Garcia-Moure M; Labiano S; Laspidea V; Gonzalez-Huarriz M; Zalacain M; Marrodan L; Martinez-Velez N; De la Nava D; Ausejo I; Hervás-Stubbs S; Herrador G; Chen Z; Hambardzumyan D; Patino Garcia A; Jiang H; Gomez-Manzano C; Fueyo J; Gállego Pérez-Larraya J; Alonso M
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34281988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of NIR therapy and regulatory T cell modulation using layer-by-layer hybrid nanoparticles for effective cancer photoimmunotherapy.
    Ou W; Jiang L; Thapa RK; Soe ZC; Poudel K; Chang JH; Ku SK; Choi HG; Yong CS; Kim JO
    Theranostics; 2018; 8(17):4574-4590. PubMed ID: 30279723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional Nanoassembly for MRI-Trackable Dendritic Cell Dependent and Independent Photoimmunotherapy.
    Xiao B; Xu H; Xu X; Pan Y; Shi X; Yuan P; Slater NKH; Sun W; Tang J; Shen Y; Gao J
    Nano Lett; 2023 Oct; 23(19):9133-9142. PubMed ID: 37767907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-beam of light priming the immune responses and boosting cancer photoimmunotherapy.
    Sun Y; Han R; Wang J; Qin Y; Ren Z; Feng X; Liu Q; Wang X
    J Control Release; 2022 Oct; 350():734-747. PubMed ID: 36063959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity.
    Ogawa M; Tomita Y; Nakamura Y; Lee MJ; Lee S; Tomita S; Nagaya T; Sato K; Yamauchi T; Iwai H; Kumar A; Haystead T; Shroff H; Choyke PL; Trepel JB; Kobayashi H
    Oncotarget; 2017 Feb; 8(6):10425-10436. PubMed ID: 28060726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of photoimmunotherapy followed by liposomal daunorubicin in a mixed tumor model: a demonstration of the super-enhanced permeability and retention effect after photoimmunotherapy.
    Sano K; Nakajima T; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2014 Feb; 13(2):426-32. PubMed ID: 24356818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal.
    Isoyama S; Mori S; Sugiyama D; Kojima Y; Tada Y; Shitara K; Hinohara K; Dan S; Nishikawa H
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34446575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
    Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
    Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
    World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.